{
  "pmid": "39185955",
  "uid": "39185955",
  "title": "Rivaroxaban for Patients with Intermittent Claudication.",
  "abstract": "BACKGROUND: The combination of rivaroxaban plus aspirin compared with aspirin alone reduces the risk of major adverse cardiovascular and limb events for high-risk patients with peripheral artery disease. It is unknown whether rivaroxaban plus aspirin improves intermittent claudication for adults with lower-risk peripheral arterial disease. METHODS: In this randomized, open-label, multicenter, 24-week clinical trial, we randomly assigned patients with peripheral artery disease and intermittent claudication to receive either 2.5 mg of rivaroxaban twice daily plus 100 mg of aspirin once daily or 100 mg of aspirin once daily. The primary outcome was a 24-week change in total walking distance, measured by the 6-minute walking test. The primary safety outcome was the incidence of major bleeding or clinically relevant nonmajor bleeding. RESULTS: Eighty-eight patients were randomly assigned to either rivaroxaban plus aspirin (n=46) or aspirin alone (n=42). The mean age was 67 years, and 54% were female. The total walking distance measured by 6-minute walk test improved by 89 ± 18 m (mean±standard error) in the rivaroxaban-plus-aspirin group versus 21 ± 16 m in the aspirin-alone group. This corresponded to an absolute difference of 68 ± 24 m (95% confidence interval [CI], 19 to 116 m; P=0.007) and a relative improvement over the aspirin-alone group of 327% (95% CI, 94 to 560%). No major bleeding events were observed in either group. CONCLUSIONS: In patients with peripheral artery disease and intermittent claudication, 2.5 mg of rivaroxaban twice daily plus 100 mg of aspirin daily improved the total walking distance by a 6-minute walking test compared with 100 mg of aspirin daily alone. (Funded by Bayer S.A.; Clinicaltrials.gov number, NCT04853719.).",
  "authors": [
    {
      "last_name": "Ramacciotti",
      "fore_name": "Eduardo",
      "initials": "E",
      "name": "Eduardo Ramacciotti",
      "affiliations": [
        "Science Valley Research Institute, São Paulo.",
        "Hospital e Maternidade Christóvão da Gama, Grupo DASA, São Paulo.",
        "Hemostasis & Thrombosis Research Laboratories, Loyola University Medical Center, Maywood, IL."
      ]
    },
    {
      "last_name": "Volpiani",
      "fore_name": "Giuliano Giova",
      "initials": "GG",
      "name": "Giuliano Giova Volpiani",
      "affiliations": [
        "Science Valley Research Institute, São Paulo.",
        "Hospital e Maternidade Christóvão da Gama, Grupo DASA, São Paulo.",
        "Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo."
      ]
    },
    {
      "last_name": "Britto",
      "fore_name": "Karen Falcão",
      "initials": "KF",
      "name": "Karen Falcão Britto",
      "affiliations": [
        "Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo."
      ]
    },
    {
      "last_name": "Agati",
      "fore_name": "Leandro Barile",
      "initials": "LB",
      "name": "Leandro Barile Agati",
      "affiliations": [
        "Science Valley Research Institute, São Paulo."
      ]
    },
    {
      "last_name": "Ribeiro",
      "fore_name": "Camilla Moreira",
      "initials": "CM",
      "name": "Camilla Moreira Ribeiro",
      "affiliations": [
        "Science Valley Research Institute, São Paulo."
      ]
    },
    {
      "last_name": "Aguiar",
      "fore_name": "Valéria Cristina Resende",
      "initials": "VCR",
      "name": "Valéria Cristina Resende Aguiar",
      "affiliations": [
        "Science Valley Research Institute, São Paulo."
      ]
    },
    {
      "last_name": "Paganotti",
      "fore_name": "Alexia",
      "initials": "A",
      "name": "Alexia Paganotti",
      "affiliations": [
        "Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo."
      ]
    },
    {
      "last_name": "Pereira",
      "fore_name": "Felipe Menegueti",
      "initials": "FM",
      "name": "Felipe Menegueti Pereira",
      "affiliations": [
        "Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo."
      ]
    },
    {
      "last_name": "Caffaro",
      "fore_name": "Roberto Augusto",
      "initials": "RA",
      "name": "Roberto Augusto Caffaro",
      "affiliations": [
        "Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo."
      ]
    },
    {
      "last_name": "Krakauer",
      "fore_name": "Rogério",
      "initials": "R",
      "name": "Rogério Krakauer",
      "affiliations": [
        "Hospital e Maternidade Christóvão da Gama, Grupo DASA, São Paulo."
      ]
    },
    {
      "last_name": "Rached",
      "fore_name": "Heron Rhydan Saad",
      "initials": "HRS",
      "name": "Heron Rhydan Saad Rached",
      "affiliations": [
        "Hospital Leforte Liberdade, Grupo DASA, São Paulo."
      ]
    },
    {
      "last_name": "Fareed",
      "fore_name": "Jawed",
      "initials": "J",
      "name": "Jawed Fareed",
      "affiliations": [
        "Hemostasis & Thrombosis Research Laboratories, Loyola University Medical Center, Maywood, IL."
      ]
    },
    {
      "last_name": "Wolosker",
      "fore_name": "Nelson",
      "initials": "N",
      "name": "Nelson Wolosker",
      "affiliations": [
        "Hospital Israelita Albert Einstein, São Paulo."
      ]
    },
    {
      "last_name": "Anand",
      "fore_name": "Sonia S",
      "initials": "SS",
      "name": "Sonia S Anand",
      "affiliations": [
        "Department of Medicine, Population Health Research Institute, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada."
      ]
    },
    {
      "last_name": "Eikelboom",
      "fore_name": "John W",
      "initials": "JW",
      "name": "John W Eikelboom",
      "affiliations": [
        "Department of Medicine, Population Health Research Institute, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada."
      ]
    },
    {
      "last_name": "Chang",
      "fore_name": "Chiann",
      "initials": "C",
      "name": "Chiann Chang",
      "affiliations": [
        "Department of Statistics, Institute of Mathematics and Statistics, University of São Paulo, São Paulo."
      ]
    },
    {
      "last_name": "Lopes",
      "fore_name": "Renato D",
      "initials": "RD",
      "name": "Renato D Lopes",
      "affiliations": [
        "Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC."
      ]
    }
  ],
  "journal": {
    "title": "NEJM evidence",
    "iso_abbreviation": "NEJM Evid",
    "issn": "2766-5526",
    "issn_type": "Electronic",
    "volume": "3",
    "issue": "9",
    "pub_year": "2024",
    "pub_month": "Sep"
  },
  "start_page": "EVIDoa2400021",
  "pages": "EVIDoa2400021",
  "language": "eng",
  "publication_types": [
    "Journal Article",
    "Randomized Controlled Trial",
    "Multicenter Study"
  ],
  "keywords": [
    "Humans",
    "Rivaroxaban",
    "Intermittent Claudication",
    "Female",
    "Male",
    "Aged",
    "Aspirin",
    "Middle Aged",
    "Factor Xa Inhibitors",
    "Peripheral Arterial Disease",
    "Platelet Aggregation Inhibitors",
    "Drug Therapy, Combination",
    "Treatment Outcome",
    "Hemorrhage"
  ],
  "article_ids": {
    "pubmed": "39185955",
    "doi": "10.1056/EVIDoa2400021"
  },
  "doi": "10.1056/EVIDoa2400021",
  "dates": {
    "completed": "2024-08-27",
    "revised": "2024-09-18"
  },
  "chemicals": [
    "Rivaroxaban",
    "Aspirin",
    "Factor Xa Inhibitors",
    "Platelet Aggregation Inhibitors"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "current_affiliation",
    "retrieved_date": "2025-07-30T14:04:23.381658",
    "pmid": "39185955"
  }
}